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The post-translational modification of proteins by O-linked β-N-acetylglucosamine 
(O-GlcNAc) is regulated by a unique couple of enzymes. O-GlcNAc transferase (OGT) 
transfers the GlcNAc residue from UDP-GlcNAc, the final product of the hexosamine 
biosynthetic pathway (HBP), whereas O-GlcNAcase (OGA) removes it. This study and 
others show that OGT and O-GlcNAcylation levels are increased in cancer cell lines. In 
that context, we studied the effect of OGT silencing in the colon cancer cell lines HT29 
and HCT116 and the primary colon cell line CCD841CoN. Herein, we report that OGT 
silencing diminished proliferation, in vitro cell survival and adhesion of primary and cancer 
cell lines. SiOGT dramatically decreased HT29 and CCD841CoN migration, CCD841CoN 
harboring high capabilities of migration in Boyden chamber system when compared 
to HT29 and HCT116. The expression levels of actin and tubulin were unaffected by 
OGT knockdown but siOGT seemed to disorganize microfilament, microtubule, and 
vinculin networks in CCD841CoN. While cancer cell lines harbor higher levels of OGT 
and O-GlcNAcylation to fulfill their proliferative and migratory properties, in agreement 
with their higher consumption of HBP main substrates glucose and glutamine, our data 
demonstrate that OGT expression is not only necessary for the biological properties of 
cancer cell lines but also for normal cells.
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inTrODUcTiOn
O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) is the modification by a single residue 
of N-acetylglucosamine (GlcNAc) of nucleocytoplasmic and mitochondrial proteins. This modifi-
cation is highly dynamic and is regulated by two enzymes: the O-GlcNAc transferase (OGT), which 
adds the residue and the O-GlcNAcase (OGA), which removes it (Figure 1A). O-GlcNAcylation 
Abbreviations: GFAT, Glutamine:Fructose-6-phosphate amidotransferase; NAGK, N-acetylglucosamine kinase; OGA, 
O-GlcNAcase (O-linked N-acetylglucosaminidase); OGT, O-GlcNAc transferase (O-linked N-acetylglucosaminyl transferase).
FigUre 1 | colon cancer cell lines have increased-OgT, Oga, and O-glcnacylated proteins levels. (a) O-GlcNAcylation is dependent upon cell 
nutrient status and is regulated by OGT and OGA. The unique glycosyltransferase OGT transfers the GlcNAc moiety from UDP-GlcNAc to target proteins 
and the glycosidase OGA hydrolyzes the glycosidic bond; therefore, O-GlcNAcylation is versatile. Glucose and glutamine are the main substrates of the 
hexosamine biosynthetic pathway, which gives rise to UDP-GlcNAc. Moreover, the consumption of these two metabolites is increased in cancer cell lines. 
The flux of the hexosamine pathway is controlled by the rate-limiting enzyme GFAT. The level of UDP-GlcNAc, and consequently of O-GlcNAcylation, is 
tightly dependent upon the nutrient status of the cell. After its release by OGA, GlcNAc is reactivated by NAGK in the GlcNAc salvage pathway. HK, 
hexokinase; GPI, phosphoglucose isomerase; GFAT, glutamine:fructose-6-phosphate amidotransferase; GNPNAT1, glucosamine-6-phosphate acetyl 
transferase; AGM1, phospho-N-acetylglucosamine mutase; UAP, uridine di-phospho-N-acetylglucosamine pyrophosphorylase; NAGK, N-acetylglucosamine 
kinase; OGA, O-GlcNAcase (O-linked N-acetylglucosaminidase); OGT, O-GlcNAc transferase (O-linked N-acetylglucosaminyl transferase).  
(B) O-GlcNAcylation, OGT, OGA, and GFAT levels in the three colon cell lines used in the study were assessed by Western blot. (c) CCD841CoN, HT29, 
and HCT116 cells were cultured in various concentrations of glucose (0, 5.5, and 25 mM) and with (2 mM) or without glutamine. O-GlcNAcylated proteins 
were analyzed by Western blot.
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cycling is involved in many fundamental functions, including 
translation (1), transcription (2), cell signaling (3), and protein 
trafficking (4). Deregulation of O-GlcNAcylation dynamics 
actively participates in tumorigenesis and in the etiology of 
cancer (5). A synergy between unhealthy diet and cancer 
development is proposed because of the status of OGT’s natural 
substrate, UDP-GlcNAc, which is positioned at the crossroad 
of metabolic pathways (6–8). Moreover, glucose transport and 
consumption is upregulated in cancer cells. This alteration of 
metabolism is called the “Warburg effect,” Otto Warburg having 
devoted a large part of his research activities to “the origin of 
cancer cells” (9).
The initial observation made by Cori and Cori (10) con-
cluded that a hen’s wing having Rous sarcoma produced more 
lactic acid than the normal wing. Therefore, it was suggested 
that a deficiency in glucose metabolism was responsible for 
carcinogenesis even if it is now accepted that it is rather a con-
sequence. Interestingly, cancer cells not only increase glucose 
TaBle 1 | characteristics of the cell lines used in the study.
cell line gender, age, disease, 
Msi status
characterized deletions, 
mutations, and comments
CCD841CoN Female, 21-week 
gestation (fetus), normal 
colon
According to ATCC, the definitive 
evidence of epithelial origin is lacking
HT29 Female, 44 years, 
colorectal 
adenocarcinoma, MSS
Deletion in APC (del1555_2843)
Mutation in p53 (codon 273: R273H)
Mutation in BRAF (codon 600: V600E)
Mutation in PI3KCA (P449T)
HCT116 Male, 48 years, 
colorectal carcinoma 
(proximal), HNPCC, MSI
Mutation in Ras (codon 13: G13D)
Mutation in PI3KCA (codon 1047: 
H1047R)
Deletion in β-catenin (del45)
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consumption but also use more glutamine (11). Glutamine is 
necessary for both non-essential amino-acids and for purine/
pyrimidine base synthesis in highly proliferative cells (11). In 
cancer cells, glucose is also used for production of amino-acids 
and lipids. A large part of the increased-glucose flux is diverted 
toward the pentose phosphate pathway (PPP) to generate 
deoxyribose needed for the synthesis of DNA. Interestingly, both 
glutamine and glucose are limiting substrates of the hexosamine 
biosynthetic pathway (HBP) (12). HBP results in UDP-GlcNAc 
synthesis subsequently used by OGT to modify proteins (6). 
Consequently, through O-GlcNAcylation, HBP activation is 
involved in cellular structure construction as well as regulation 
of metabolic flux, signaling pathways, cell homeostasis processes, 
and tumorigenesis. Increased O-GlcNAcylation levels have been 
reported in diverse kind of cancers: breast (5, 13, 14), lung (15), 
liver (16), prostate (17), chronic lymphocytic leukemia (18), 
colon (15,  19–21), and colitis-associated cancer patients (22). 
Regarding these recent observations, we wondered whether 
silencing OGT expression affects biological properties of colon 
cancer-derived cell lines (HT29 and HCT116) in comparison to 
a normal colon cell line (CCD841CoN, derived from a fetus). 
Although O-GlcNAcylation and its cycling enzymes are more 
elevated in cancer cell lines, we found that both normal and can-
cer cell lines are impacted by siOGT. While the fetal colon cells 
are highly mobile, we demonstrate that OGT knockdown slows 
down their migration property in addition to a disturbance of 
the cytoskeleton. Together, these data show that OGT is crucial 
for the biological properties of cancer and non-cancer cell lines. 
However, we suggest that cancer cell lines are highly sensitive 
to metabolic deprivation and OGT knockdown, accordingly 
to their high-demand in nutrients, in particular glucose and 
glutamine.
MaTerials anD MeThODs
cell culture and Transfection of sirna
HT29 and HCT116 cells were maintained in a Dulbecco’s 
modified Eagle’s medium (DMEM) and CCD841CoN cells were 
maintained in an Eagle’s Minimum Essential Medium (EMEM) 
(Lonza) (Table  1). The three cell lines were maintained in a 
medium supplemented with 10% (v/v) fetal calf serum, 2 mM 
l-glutamine, 5 IU/mL penicillin, and 50 μg mL−1 streptomycin 
at 37°C in a 5% (v/v) CO2-enriched humidified atmosphere. 
Cells were reverse-transfected with Lipofectamine RNAiMax 
(Life Technologies) according to manufacturer’s instructions 
using 5  nM small interfering RNA targeting OGT (21) or a 
control siRNA (MISSION siRNA universal negative control #1, 
SIGMA).
sDs-Page, Western Blotting, and 
antibody staining
Equal amounts of protein (determined by the BCA method) 
were resolved on 10% SDS-PAGE under reducing conditions and 
proteins were electroblotted on nitrocellulose (GE Healthcare). 
Efficiency of the transfer and equal loading were verified using 
Ponceau red staining. Membranes were first saturated for 45 min 
with 5% (m/v) non-fatty acid milk in Tris-buffered saline (TBS)-
Tween buffer [15  mM Tris/HCl, 140  mM NaCl, and 0.05% 
Tween20 (v/v), pH 8.0]. Mouse monoclonal anti-O-GlcNAc (RL2, 
Ozyme) was used at a dilution of 1:4,000. Chicken anti-OGA 
(345, generously provided by Hart, the Johns Hopkins School of 
Medicine, Baltimore, MD, USA) was used at a dilution of 1:2,000. 
Mouse monoclonal anti-tubulin (Santa Cruz Biotechnology) and 
mouse polyclonal anti-GAPDH (Santa Cruz Biotechnology) were 
used at a dilution of 1:3,000; rabbit polyclonal anti-OGT (TI14, 
Sigma-Aldrich) was used at a dilution of 1:4,000; anti-GFAT 
(Abcam). Membranes were incubated with the different antibod-
ies overnight at 4°C, then washed three times with TBS-Tween 
for 10 min, and incubated with either an anti-rabbit or an anti-
mouse horseradish peroxidase-labeled secondary antibody at a 
dilution of 1:10,000 for 1 h. Finally, three washes of 10 min each 
were performed with TBS-Tween and the detection was carried 
out by chemiluminescence imaging (Fusion Solo system, Vilber 
Lourmat).
cell adhesion assay
Cells (1 × 104) were seeded 48 h after transfection with siRNA 
targeting OGT or a control siRNA in 96-well plates (Thermo 
Fisher Scientific) in DMEM for HCT116 and HT29, and EMEM 
for CCD841 CoN, containing 10% (v/v) fetal calf serum. At the 
indicated time periods, medium containing not attached cells was 
removed and replaced with fresh medium. Viability of adherent 
cells was analyzed using the MTS method (Promega) according 
to the manufacturer’s instructions. Cell adhesion was measured 
in three independent experiments (n = 8).
Proliferation assays
HCT116 and HT29 cells (2 × 103) and CCD841 CoN (1 × 103) 
cells were seeded in 96-well plates (Thermo Fisher Scientific) 
and grown in DMEM (for HCT116 and HT29) or EMEM (for 
CCD841CoN) medium containing 10% (v/v) fetal calf serum. 
Cells were transfected two times with siRNA targeting OGT 
or a control siRNA. Cell growth was analyzed for the indicated 
time periods using the MTS reagent (Promega) according to the 
manufacturer’s instructions. Cell proliferation was evaluated in 
three independent experiments (n = 8).
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In Vitro cell survival assays
Cells (2 × 103) were seeded in 100-mm Petri dishes. After attach-
ment, cells were transfected four times with siRNA targeting 
OGT or a control siRNA. Two weeks later, cells were fixed in 4% 
(m/v) paraformaldehyde (Sigma-Aldrich) for 20  min at room 
temperature and stained with crystal violet (0.1% w/v, 30 min, 
at room temperature) for 30 min at room temperature. Colonies 
were then washed several times with water and left to dry at room 
temperature. In vitro cell survival assays were performed in two 
independent experiments (n = 4).
cell Migration analysis
Wound Healing Assays
Wound healing assays were performed using culture-insert-
μDish (Ibidi) composed of two chambers (growth area per 
well 0.22 cm2) separated by a wall (width of 500 μm). Culture-
inserts were put in 12-well plates. 1 × 104 CCD841CoN and 
4 × 104 HCT116 and HT29 cells were seeded into the chambers 
48 h after transfection. After cell attachment overnight at 37°C 
in 10% (v/v) fetal calf serum-containing medium (DMEM for 
HCT116 and HT29 and EMEM for CCD841CoN) culture-
inserts were gently removed to form the cell-free gap. For each 
cell line, pictures were taken 24 h later to monitor the heal-
ing of the cell-free gap on a Nikon Eclipse Ti-U microscope. 
Wound healing assays were performed in three independent 
experiments (n = 6).
Transwell System
Forty-eight hours after transfection cells (5 × 104) were seeded 
in the upper surface of a Transwell 12-well (size of the pores, 
8 μm) (BD Biosciences) and cultured for 24 h in a 0.2% (v/v) 
fetal calf serum-containing medium (DMEM for HCT116 
and HT29 and EMEM for CCD841 CoN). After incubation, 
cells were fixed in 4% (m/v) paraformaldehyde for 20  min 
at room temperature and stained with Hoechst 33258 for 
15  min in the dark at room temperature. Then, cells in the 
upper chamber of the well’s porous membrane were removed 
by scraping with a cotton swab and washed several times with 
phosphate-buffered saline (PBS, pH 7.2). The membrane was 
mounted on slide with Glycergel mounting medium (Dako). 
The migrated cells were counted under ×20 magnification and 
the mean number of cells was evaluated in three independent 
experiments (n = 6).
confocal Microscopy
Cells were cultured on glass coverslips in DMEM (for HCT116 
and HT29) and EMEM (for CCD841CoN) medium contain-
ing 10% (v/v) fetal calf serum. Cells were washed twice in PBS 
and fixed in 4% (m/v) paraformaldehyde for 20  min at room 
temperature. After washing with PBS, cells were blocked and 
permeabilized in PBS containing 0.2% (m/v) BSA and 0.1% 
(m/v) saponin for 1  h. Cells were incubated for 4  h at room 
temperature with polyclonal anti-tubulin (1:200) (Santa Cruz 
Biotechnology) or monoclonal anti-vinculin (1:200) (Abcam), 
diluted in PBS-BSA-saponin. Cells were washed three times in 
PBS–BSA–saponin and incubated with Alexa Fluor® 488 and 
Alexa Fluor® 568 (Life Technologies) or CytoPainter Phalloidin-
iFluor 488 Reagent (1:1000) (Abcam) in PBS–BSA–saponin for 
1 h at room temperature. Following washings, cells were stained 
with Hoechst during 15 min in the dark at room temperature. 
After washings with PBS and deionized water, cells were 
mounted with Glycergel mounting medium. Data were finally 
collected using the ZEN2012 software.
statistical analysis
Student’s t-test (Excel) was used for statistical analysis (unpaired/
two-tailed); p-values were calculated and reported accordingly 
(*P < 0.05, **P < 0.01, ***P < 0.001).
resUlTs
hT29 and hcT116 cells exhibit higher 
levels of O-glcnacylation cycling 
enzymes compared to ccD841con
Two colon cancer cell lines, HT29 and HCT116, respectively, 
derived from an adenocarcinoma and from a carcinoma 
(Table 1) and the fetal colon cell line CCD841CoN were analyzed 
by Western blot to determine to the levels of O-GlcNAcylation, 
OGT, OGA, and Glutamine:Fructose-6-P amidotransferase 
(GFAT), the rate-limiting enzyme of the HBP (Figures  1A,B). 
As shown by western blotting results, O-GlcNAcylated proteins 
levels, as well as OGA, OGT, and GFAT protein expression were 
much more elevated in cancer cell lines compared to the fetal cell 
line (Figure 1B), in accordance with our previous study (23). We 
next checked whether the three cell lines’ O-GlcNAcylation levels 
were dependent upon glucose and glutamine, the two pivotal 
substrates of the HBP (Figure 1A). Thus, overnight depletion of 
either glucose or glutamine reduced O-GlcNAcylation processes, 
more particularly in HT29 and HCT116 cells (Figure 1C), which 
are high consumers of these two nutrients like most cancer 
cell lines (7–11). Moreover, we noticed that CCD841CoN were 
particularly sensitive to glucose starvation, leading to a high 
mortality rate.
Therefore, we next assessed the impact of OGT knockdown on 
the biological properties of these cell lines.
OgT Knockdown Decreases cell 
Proliferation, reduces In Vitro cell 
survival, and impairs cell adhesion
The efficiency of siOGT was checked for the three cell lines. As 
expected, transfection of HCT116, HT29, and CCD841CoN with 
siOGT decreased the expression of the glycosyltransferase and 
drastically reduced O-GlcNAcylation levels (Figure 2).
We previously observed that the inhibitor of OGA, NButGT 
(24), accelerated the proliferation rate of MCF7 cells (23), 
whereas the potent OGT inhibitor, Ac-5SGlcNAc (25), slightly 
delayed cell proliferation (26). In the present study, we tested 
the impact of siOGT on the proliferation rate of CCD841CoN, 
FigUre 2 | OgT knockdown decreases O-glcnacylation contents in 
colon cells. Forty-eight hours after transfection, the efficiency of siOGT vs. 
siCtrl was tested in the three cell lines used in the study. OGT and 
O-GlcNAcylation levels were measured by Western blot. The arrowhead 
indicates an unspecific band.
FigUre 3 | OgT silencing slows down cell proliferation. Colon cell proliferation was monitored for 4 days in conditions of OGT silencing vs. siCtrl. Each day, 
cell growth was determined using the MTS reagent method. (a) CCD841CoN; (B) HT29; (c) HCT116. (D) The decrease of cell proliferation for each cell line was 
calculated and reported (±SD). (Student’s t-test: *P < 0.05, **P < 0.01, ***P < 0.001).
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HT29, and HCT116 cells (Figures  3A–C, respectively). As 
expected and in agreement with our previous observations (26), 
OGT silencing decelerated the proliferation rate of the three cell 
lines, with an average 20% decrease for CCD841CoN and HT29, 
and 45% decrease for HCT116 (Figure 3D). To go further, we 
tested the ability of colon cells to grow into a colony (in vitro 
cell survival assay) in response to siOGT (Figure  4A). Both 
for HT29 and HCT116 cells, the reduction of OGT expression 
dramatically decreased in vitro survival compared with siCtrl-
transfected cells (Figure 4B). The ability of a single cell to grow 
into a colony is characteristic of cancer cells. Accordingly, we 
were unable to assess the formation of colonies for the primary 
cell line CCD841CoN. These experiments showed that OGT 
and, consequently, O-GlcNAcylation are needed for colon cells 
growth.
We next performed cell adhesion assays for the indicated time 
periods (Figure 5). While siOGT decreased the adhesion of the 
three cell lines, we observed a higher impact of OGT silencing on 
the adhesion of HT29 and CCD841CoN cells. OGT is, therefore, 
necessary for adhesion of colon cells.
FigUre 4 | OgT knockdown reduces colony forming potential of 
colon cells. CCD841CoN, HT29, and HCT116 cells were seeded and 
transfected with siCtrl or siOGT in 100-mm Petri dishes. Colonies were 
stained with crystal violet after 2 weeks. (a) Representative results of colony 
staining in siCtrl and siOGT-transfected CCD841CoN, HT29, and HCT116 
cells. For CCD841CoN cell line pictures were taken under ×20 magnification. 
(B) Colony counting in siCtrl and siOGT for HT29 and HCT116 cells were 
quantified (mean values ± SD). (Student’s t-test: *P < 0.05).
6
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FigUre 5 | OgT silencing reduces cell adhesion. Cell adhesion was 
monitored for the different cell lines 48 h after siOGT or siCtrl treatment from 
15 min to 4 h after seeding as detailed in the experimental procedures 
section. Mean values (±SD) were reported. (a) CCD841CoN; (B) HT29; (c) 
HCT116. (Student’s t-test: *P < 0.05, **P < 0.01, ****P < 0.001).
OgT Knockdown reduces  
Migration of colon cells
We wondered whether OGT is involved in the migration of 
colon cells. For this matter, we used two distinct approaches: 
the wound healing assay using culture-inserts μDish and the 
Transwell system assay, a more quantitative method. Wound 
healing was assessed 24 h after the culture-inserts were removed 
(Figure 6). While CCD841CoN were able to fill in the cell-free 
gap in 24 h, the gap separating the two edges of the migratory 
HT29 cells was tight at t = 24 h. However, HCT116 only slowly 
recovered the wound after 24  h. OGT knockdown impaired 
the closure of the wound for CCD841CoN and HT29 cells as 
no significant migration was measured after siOGT treatment 
in comparison to siControl. Nevertheless, even if the migration 
of the HCT116 cells was slow, siOGT also delayed significantly 
this process (Figure 6B). Furthermore, these first observations 
were corroborated by the more quantitative Transwell assay 
(Figure  7A). HCT116 cells did not display any significant 
migration across the filter pores even in the siControl conditions. 
Regarding HT29, while these cells harbored a weak migration 
in Boyden chambers, a significant decrease was measured when 
OGT was silenced. Surprisingly, despite their size, CCD841CoN 
cells exhibited a high capacity of migration compared to HT29 
7Steenackers et al. OGT Knockdown Reduces Colon Cells Properties
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FigUre 6 | OgT silencing slows down colon cells migration. (a) Representative wound healing assays of siCtrl and siOGT-transfected CCD841CoN, HT29, 
and HCT116 cells are represented. The dotted lines correspond to the wound at t = 0. At the bottom left is indicated the width of the wound at t = 0 or at t = 24 h 
established by image analysis. Bar, 100 μm (B) Mean values (±SD) of the width of the wounds at t = 24 h in siCtrl and siOGT for the three colon cell lines. (Student’s 
t-test: *P < 0.05, ***P < 0.001).
and HCT116 in Boyden chambers. OGT silencing dramatically 
reduced their migratory capabilities, in accordance with wound 
healing assays.
We hypothesized that a larger cytoskeleton network could con-
fer the high-migratory properties of CCD841CoN cells of which 
the epithelial origin has not been clearly established (Table 1). 
First, we showed that actin, the major component of the microfila-
ment network, was more heavily expressed in CCD841CoN cells 
compared to HT29 and HCT116 cells (Figure 7B). Interestingly, 
siOGT did not impact the expression of both actin and tubulin, 
another major component of the cytoskeleton network. Analysis 
of the cytoskeleton by confocal microscopy (Figures  7C–E) 
indicated that the cytoskeletal networks are more elaborated in 
CCD841CoN, which reinforces the doubt about the epithelial 
origin of this cell line according to ATCC. Surprisingly, OGT 
silencing did not impact the expression of actin, tubulin, and 
vinculin, a cytoskeletal protein associated with cell–cell and 
cell–matrix junctions. On the other hand, siOGT greatly affected 
8Steenackers et al. OGT Knockdown Reduces Colon Cells Properties
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the cytoskeletal networks and cell morphology in CCD841CoN 
cells. The cell shape appeared stocky and stunted, whereas the 
microfilament network, responsible for cell migration, was less 
extended.
DiscUssiOn
O-GlcNAcylation is fundamental for cell viability as demon-
strated by the non-viability of OGT-depleted ES cells (27). 
FigUre 7 | OgT silencing reduces migration of ccD841con and hT29 cells in Boyden chamber system. (a) Colon cells were transfected with siCtrl or 
siOGT. Twenty-four hours after seeding in Transwell 12-well plates, cells were visualized by Hoechst staining. Mean values (±SD) of the migrated cells are reported. 
(B) Expression of β-tubulin and actin were analyzed by Western blot for siCtrl vs. siOGT-transfected colon cell lines. GAPDH was used as a loading control. (c–e) 
Morphology of CCD841CoN (c), HT29 (D), and HCT116 (e) cells was assessed by confocal microscopy. Tubulin and vinculin were visualized using specific-
directed antibody and actin using the CytoPainter Phalloidin-iFluor 488 Reagent. Bar, 20 μm.
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Whereas three isoforms were described for OGT (nucleocy-
toplasmic, short, and mitochondrial isoforms), this enzyme is 
encoded by a single gene and downregulating its expression 
or inhibiting its catalytic activity affects major fundamental 
biological functions (3, 26, 27). Moreover, a deregulation in the 
O-GlcNAcylation cycling is involved in the etiology of diverse 
pathologies, such as type-2 diabetes, Alzheimer’s, and cancers 
(6). Intriguingly, due to the correlation between UDP-GlcNAc, 
O-GlcNAcylation, and nutrients availability, diseases associated 
with unhealthy diet and metabolic disorders may be tightly 
linked to O-GlcNAcylation imbalance (28). It is, therefore, cru-
cial to better understand through which metabolic mechanisms 
lifestyles negatively impact human health. Particularly, some 
cancers, among which colorectal cancers, are synergistically 
favored by metabolic problems and unhealthy lifestyles (29, 
30). Elevated-O-GlcNAcylation level was described in many 
cancers, even if the reasons and impacts of this increased level 
remain obscure. For example, breast cancer cells have increased-
O-GlcNAcylation and OGT levels, and a reduction of OGT 
expression correlated to tumor growth decrease (5). High levels 
of OGT and its product, O-GlcNAcylation, were also reported 
in colon cancers and cancer cell lines (15, 19–21) and colitis-
associated cancer patients (22) but very few initiatives to measure 
the effect of OGT knockdown were conducted. Among those few 
studies, OGA inhibition or shOGT exhibited no significant effect 
on HT29 cell invasion but enhanced and reduced, respectively, 
their anchorage-independent growth (15). Furthermore, OGT 
knockdown inhibited anchorage-independent growth (14), but 
contradictory results were also reported (19). This last study indi-
cated that OGA silencing changed the anchorage-independent 
growth and the morphology of the primary colorectal cancer 
cell SW480 and of its metastatic clone SW620 (19). Whereas 
one previous study showed altered gene expression related to 
actin reorganization and cell migration in siOGA-transfected 
cells (19), we found that OGT silencing also modifies cell shape 
features of the fetal human colon cell line CCD841CoN. In our 
hands, siOGT did not modify the expression of actin but we 
suspected that actin-binding proteins are up- or downregulated 
when OGT is silenced. In that sense, OGT promotes breast cancer 
cells invasion in a cofilin-dependent manner. O-GlcNAcylation 
of cofilin at Ser108 localizes this actin-interacting protein to 
invadopodia (31). Also, under conditions of low OGT expres-
sion, actin may be itself affected by defective O-GlcNAcylation. 
In a previous work, we mapped a major O-GlcNAcylation site 
within the 318–324 region of β-actin expressed in Xenopus laevis 
oocytes (32) and later, one O-GlcNAcylation site was localized 
in the domain four of rat actin (33). Nevertheless, the function 
of actin O-GlcNAcylation remains to be established. In parallel, 
O-GlcNAcylation was also widely studied on tubulin, another 
major component of the cytoskeleton network. O-GlcNAcylation 
of α-tubulin reduces heterodimerization of α/β-tubulins and 
O-GlcNAcylated forms of tubulins are unable to polymerize into 
microtubule (34). Moreover, α-tubulin is heavily O-GlcNAcylated 
in primary colorectal cancer (20). These two independent studies 
tend to support our observations of a disorganization of micro-
tubules in the primary colon cell line, while no significant effect 
of siOGT was found in the two colon cancer lines.
Beyond the effect of O-GlcNAcylation on structural proteins 
in a pathologic context, downregulation of OGT must interfere 
with the expression and/or the activity of regulatory proteins. 
A comparison between primary breast malignant tumors and 
benign tumors revealed the O-GlcNAcylation of crucial com-
ponents of the “Warburg effect” only in cancer (14). One of the 
characteristics of cancer cells is the shift from an oxidative to a 
non-oxidative consumption of glucose. Oncogenic signaling 
pathways controlling the transcription factor hypoxia-inducible 
factor-1 (HIF1) alpha are responsible for this metabolic shift.
HIF1α stability is dependent upon O-GlcNAcylation level 
(35). GLUT1 expression, one of the HIF1α’s target genes, is more 
heavily expressed when OGT is activated. Consequently, glucose 
transport into the cell is increased. Most of the glycolytic enzymes 
are modified by O-GlcNAcylation (32, 36, 37). Among those, the 
enzyme phosphofructokinase-1 (PFK1) (38) controls the entry 
of glucose into glycolysis. O-GlcNAcylation of PFK1 at Ser509 
prevents the binding of the activator Fru-2,6-bis-phosphate. 
Consequently, this modification diverts the use of glucose to the 
PPP to produce pentoses and NADPH2, respectively, used for 
nucleic acids and lipids biosynthesis. This confers an advantage 
for cancer cell to increase their proliferation rate.
O-GlcNAc transferase is critical for normal cells and cancer cell 
homeostasis and adaptation to environment. Due to the plethora 
of OGT’s targets, it is difficult to assign precisely the impact of 
OGT silencing. In light of the different elements exposed above, 
we suggest that a default of O-GlcNAcylation impacts on cell 
architecture as attested by the alteration of morphology observed 
in CCD841CoN cells and of metabolic routes. Moreover, knock-
ing-down OGT also results in inactivation of mitogen signaling 
pathways as previously established (3, 26, 39, 40).
Our observations indicate that OGT is crucial for the biologi-
cal properties of normal colon-derived cells and colon cancer cell 
lines. However, colon cancer cells express higher amounts of OGT 
and O-GlcNAcylation than normal cells. Due to the addiction of 
cancer cells for glutamine and glucose (7–10), the main substrates 
of HBP, it could be suspected that cancer cells were much more 
sensitive to changes in O-GlcNAcylation levels than normal cells 
while we found that both colon cancer and primary cell lines were 
affected by OGT silencing. OGT also interferes with cell migra-
tion, especially for the fetal cell line CCD841CoN, by reducing 
the size of the actin network, which participates in the alteration 
of the cell morphology. Along this study, we demonstrated that 
OGT impacts proliferation and migration of normal as well as 
cancer colon cells. This work highlights how O-GlcNAcylation, 
through the modulation of basic biological features, controls 
the properties of primary cells and also might initiate nutrient-
responsive cancers, such as colorectal cancer.
aUThOr cOnTriBUTiOns
AS designed, performed, and analyzed the experiments, and 
wrote the experimental procedures. SS and VD initiated the 
project, conceived, and performed experiments. SS edited the 
manuscript. SB and R-AT performed and analyzed the experi-
ments. XB analyzed the experiments and managed the study at 
INSERM U908. IY-B designed, performed, and analyzed the 
10
Steenackers et al. OGT Knockdown Reduces Colon Cells Properties
Frontiers in Endocrinology | www.frontiersin.org May 2016 | Volume 7 | Article 46
reFerences
1. Zhu Y, Liu TW, Cecioni S, Eskandari R, Zandberg WF, Vocadlo DJ. O-GlcNAc 
occurs cotranslationally to stabilize nascent polypeptide chains. Nat Chem Biol 
(2015) 11:319–25. doi:10.1038/nchembio.1774 
2. Hardivillé S, Hoedt E, Mariller C, Benaïssa M, Pierce A. O-GlcNAcylation/phos-
phorylation cycling at Ser10 controls both transcriptional activity and stability of 
delta-lactoferrin. J Biol Chem (2010) 285:19205–18. doi:10.1074/jbc.M109.080572 
3. Perez-Cervera Y, Dehennaut V, Aquino Gil M, Guedri K, Solórzano Mata CJ, 
Olivier-Van Stichelen S, et  al. Insulin signaling controls the expression of 
O-GlcNAc transferase and its interaction with lipid microdomains. FASEB J 
(2013) 27:3478–86. doi:10.1096/fj.12-217984 
4. Chun YS, Park Y, Oh HG, Kim TW, Yang HO, Park MK, et al. O-GlcNAcylation 
promotes non-amyloidogenic processing of amyloid-β protein precursor via 
inhibition of endocytosis from the plasma membrane. J Alzheimers Dis (2015) 
44:261–75. doi:10.3233/JAD-140096 
5. Caldwell SA, Jackson SR, Shahriari KS, Lynch TP, Sethi G, Walker S, et  al. 
Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis 
through targeting of the oncogenic transcription factor FoxM1. Oncogene 
(2010) 29:2831–42. doi:10.1038/onc.2010.41 
6. Lefebvre T, Dehennaut V, Guinez C, Olivier S, Drougat L, Mir AM, et  al. 
Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the 
etiology of cardiovascular disorders, type-2 diabetes and Alzheimer’s disease. 
Biochim Biophys Acta (2010) 1800:67–79. doi:10.1016/j.bbagen.2009.08.008 
7. Fardini Y, Dehennaut V, Lefebvre T, Issad T. O-GlcNAcylation: a new cancer 
hallmark? Front Endocrinol (2013) 4:99. doi:10.3389/fendo.2013.00099 
8. Jóźwiak P, Forma E, Bryś M, Krześlak A. O-GlcNAcylation and metabolic 
reprograming in cancer. Front Endocrinol (2014) 5:145. doi:10.3389/
fendo.2014.00145 
9. Warburg O. On the origin of cancer cells. Science (1956) 123:309–14. 
doi:10.1126/science.123.3191.309 
10. Cori CF, Cori GT. The carbohydrate metabolismof tumors: I, the free sugar, 
lactic acid, and glycogen content of malignant tumors. J Biol Chem (1925) 
64:11–22. 
11. Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in 
cancer. Trends Biochem Sci (2010) 35:427–33. doi:10.1016/j.tibs.2010.05.003 
12. Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway medi-
ating glucose-induced desensitization of the glucose transport system. Role of 
hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 
(1991) 266:4706–12. 
13. Gu Y, Mi W, Ge Y, Liu H, Fan Q, Han C, et  al. GlcNAcylation plays an 
essential role in breast cancer metastasis. Cancer Res (2010) 70:6344–51. 
doi:10.1158/0008-5472.CAN-09-1887 
14. Champattanachai V, Netsirisawan P, Chaiyawat P, Phueaouan T, 
Charoenwattanasatien R, Chokchaichamnankit D, et  al. Proteomic analysis 
and abrogated expression of O-GlcNAcylated proteins associated with primary 
breast cancer. Proteomics (2013) 13:2088–99. doi:10.1002/pmic.201200126 
15. Mi W, Gu Y, Han C, Liu H, Fan Q, Zhang X, et al. O-GlcNAcylation is a novel 
regulator of lung and colon cancer malignancy. Biochim Biophys Acta (2011) 
1812:514–9. doi:10.1016/j.bbadis.2011.01.009 
16. Zhu Q, Zhou L, Yang Z, Lai M, Xie H, Wu L, et al. O-GlcNAcylation plays a role 
in tumor recurrence of hepatocellular carcinoma following liver transplanta-
tion. Med Oncol (2012) 29:985–93. doi:10.1007/s12032-011-9912-1 
17. Lynch TP, Ferrer CM, Jackson SR, Shahriari KS, Vosseller K, 
Reginato  MJ. Critical role of O-Linked β-N-acetylglucosamine transferase 
in prostate cancer invasion, angiogenesis, and metastasis. J Biol Chem (2012) 
287:11070–81. doi:10.1074/jbc.M111.302547 
18. Shi Y, Tomic J, Wen F, Shaha S, Bahlo A, Harrison R, et  al. Aberrant 
O-GlcNAcylation characterizes chronic lymphocytic leukemia. Leukemia 
(2010) 24:1588–98. doi:10.1038/leu.2010.152 
19. Yehezkel G, Cohen L, Kliger A, Manor E, Khalaila I. O-linked β-N-acetyl-
glucosaminylation (O-GlcNAcylation) in primary and metastatic colorectal 
cancer clones and effect of N-acetyl-β-d-glucosaminidase silencing on cell 
phenotype and transcriptome. J Biol Chem (2012) 287:28755–69. doi:10.1074/
jbc.M112.345546 
20. Phueaouan T, Chaiyawat P, Netsirisawan P, Chokchaichamnankit D, 
Punyarit  P, Srisomsap C, et  al. Aberrant O-GlcNAc-modified proteins 
expressed in primary colorectal cancer. Oncol Rep (2013) 30:2929–36. 
doi:10.3892/or.2013.2794 
21. Olivier-Van Stichelen S, Dehennaut V, Buzy A, Zachayus JL, Guinez C, 
Mir  AM, et  al. O-GlcNAcylation stabilizes β-catenin through direct com-
petition with phosphorylation at threonine 41. FASEB J (2014) 28:3325–38. 
doi:10.1096/fj.13-243535 
22. Yang YR, Kim DH, Seo YK, Park D, Jang HJ, Choi SY, et  al. Elevated 
O-GlcNAcylation promotes colonic inflammation and tumorigenesis by 
modulating NF-κB signaling. Oncotarget (2015) 6:12529–42. doi:10.18632/
oncotarget.3725 
23. Olivier-Van Stichelen S, Guinez C, Mir AM, Perez-Cervera Y, Liu C, 
Michalski JC, et al. The hexosamine biosynthetic pathway and O-GlcNAcylation 
drive the expression of β-catenin and cell proliferation. Am J Physiol Endocrinol 
Metab (2012) 302:E417–24. doi:10.1152/ajpendo.00390.2011 
24. Yuzwa SA, Macauley MS, Heinonen JE, Shan X, Dennis RJ, He Y, et al. A potent 
mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of 
tau in vivo. Nat Chem Biol (2008) 4:483–90. doi:10.1038/nchembio.96 
25. Gloster TM, Zandberg WF, Heinonen JE, Shen DL, Deng L, Vocadlo DJ. Hijacking 
a biosynthetic pathway yields a glycosyltransferase inhibitor within cells. Nat 
Chem Biol (2011) 7:174–81. doi:10.1038/nchembio.520 
26. Olivier-Van Stichelen S, Drougat L, Dehennaut V, El Yazidi-Belkoura I, Guinez 
C, Mir AM, et al. Serum-stimulated cell cycle entry promotes ncOGT synthe-
sis required for cyclin D expression. Oncogenesis (2012) 1:e36. doi:10.1038/
oncsis.2012.36 
27. Shafi R, Iyer SP, Ellies LG, O’Donnell N, Marek KW, Chui D, et  al. The 
O-GlcNAc transferase gene resides on the X chromosome and is essential for 
embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci U S A 
(2000) 97:735–9. doi:10.1073/pnas.100471497 
28. Olivier-Van Stichelen S, Hanover JA. You are what you eat: O-linked 
N-acetylglucosamine in disease, development and epigenetics. Curr Opin Clin 
Nutr Metab Care (2015) 18:339–45. doi:10.1097/MCO.0000000000000188 
29. Pais R, Silaghi H, Silaghi AC, Rusu ML, Dumitrascu DL. Metabolic syndrome 
and risk of subsequent colorectal cancer. World J Gastroenterol (2009) 
15:5141–8. doi:10.3748/wjg.15.5141 
30. Renehan A, Smith U, Kirkman MS. Linking diabetes and cancer: a consensus on 
complexity. Lancet (2010) 375:2201–2. doi:10.1016/S0140-6736(10)60706-4 
31. Huang X, Pan Q, Sun D, Chen W, Shen A, Huang M, et al. O-GlcNAcylation of 
cofilin promotes breast cancer cell invasion. J Biol Chem (2013) 288:36418–25. 
doi:10.1074/jbc.M113.495713 
32. Dehennaut V, Slomianny MC, Page A, Vercoutter-Edouart AS, Jessus C, 
Michalski JC, et  al. Identification of structural and functional O-linked 
N-acetylglucosamine-bearing proteins in Xenopus laevis oocyte. Mol Cell 
Proteomics (2008) 7:2229–45. doi:10.1074/mcp.M700494-MCP200 
experiments. TL initiated the project, conceived, and coordinated 
the study, and wrote the paper. All authors reviewed the results 
and approved the final version of the manuscript.
acKnOWleDgMenTs
The authors thank the “Ligue Contre le Cancer/Comité du 
Nord,” the “Fondation ARC (Association pour la Recherche sur 
le Cancer),” the Région Nord-Pas de Calais (Cancer Regional 
Program), the University of Lille and the “Centre National de la 
Recherche Scientifique,” the “Institut National de la Santé et de 
la Recherche Médicale” for their financial support. The authors 
are also grateful to the “SIte de Recherche Intégré sur le Cancer” 
(SIRIC) ONCOLille. The authors also appreciated the help of Dr. 
Christian Slomianny and Mrs. Elodie Richard of the CCMIC 
platform (BICeL Campus Lille 1). We thank Dr. Sophie Groux-
Degroote (University Lille 1, UGSF), a fluent English speaker, for 
the final reading of our manuscript.
11
Steenackers et al. OGT Knockdown Reduces Colon Cells Properties
Frontiers in Endocrinology | www.frontiersin.org May 2016 | Volume 7 | Article 46
33. Hédou J, Bastide B, Page A, Michalski JC, Morelle W. Mapping of O-linked 
beta-N-acetylglucosamine modification sites in key contractile proteins of rat 
skeletal muscle. Proteomics (2009) 9:2139–48. doi:10.1002/pmic.200800617 
34. Ji S, Kang JG, Park SY, Lee J, Oh YJ, Cho JW. O-GlcNAcylation of tubulin 
inhibits its polymerization. Amino Acids (2011) 40:809–18. doi:10.1007/
s00726-010-0698-9 
35. Ferrer CM, Lynch TP, Sodi VL, Falcone JN, Schwab LP, Peacock DL, et  al. 
O-GlcNAcylation regulates cancer metabolism and survival stress signaling 
via regulation of the HIF-1 pathway. Mol Cell (2014) 54:820–31. doi:10.1016/j.
molcel.2014.04.026 
36. Wells L, Vosseller K, Cole RN, Cronshaw JM, Matunis MJ, Hart GW. Mapping 
sites of O-GlcNAc modification using affinity tags for serine and threonine 
post-translational modifications. Mol Cell Proteomics (2002) 1:791–804. 
doi:10.1074/mcp.M200048-MCP200 
37. Cieniewski-Bernard C, Bastide B, Lefebvre T, Lemoine J, Mounier Y, 
Michalski JC. Identification of O-linked N-acetylglucosamine proteins in rat 
skeletal muscle using two-dimensional gel electrophoresis and mass spectrom-
etry. Mol Cell Proteomics (2004) 3:577–85. doi:10.1074/mcp.M400024-MCP200 
38. Yi W, Clark PM, Mason DE, Keenan MC, Hill C, Goddard WA III, et  al. 
Phosphofructokinase 1 glycosylation regulates cell growth and metabolism. 
Science (2012) 337:975–80. doi:10.1126/science.1222278 
39. Sekine O, Love DC, Rubenstein DS, Hanover JA. Blocking O-linked GlcNAc 
cycling in Drosophila insulin-producing cells perturbs glucose-insulin 
homeostasis. J Biol Chem (2010) 285:38684–91. doi:10.1074/jbc.M110. 
155192 
40. Zhang N, Chen X. Potential role of O-GlcNAcylation and involvement of 
PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric 
cancer cells in  vitro. Biotechnol Appl Biochem (2015). doi:10.1002/bab. 
1441 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2016 Steenackers, Olivier-Van Stichelen, Baldini, Dehennaut, Toillon, 
Le Bourhis, El Yazidi-Belkoura and Lefebvre. This is an open-access article distributed 
under the terms of the Creative Commons Attribution License (CC BY). The use, 
distribution or reproduction in other forums is permitted, provided the original 
author(s) or licensor are credited and that the original publication in this journal 
is cited, in accordance with accepted academic practice. No use, distribution or 
reproduction is permitted which does not comply with these terms.
